Kedar Purushottam Phadke
Plus aucun poste en cours
Historique de carrière de Kedar Purushottam Phadke
Anciens postes connus de Kedar Purushottam Phadke
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| THERMAX LIMITED | Compliance Officer | 08/08/2017 | 19/08/2021 |
| Investor Relations Contact | 08/08/2017 | 19/08/2021 | |
| Secrétaire Général | 08/08/2017 | 19/08/2021 | |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Secrétaire Général | 19/11/2010 | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Conseiller Juridique Général | 01/12/2009 | - |
| Secrétaire Général | 01/12/2009 | - |
Statistiques
Internationale
| Inde | 4 |
Opérationnelle
| Corporate Secretary | 3 |
| General Counsel | 1 |
| Compliance Officer | 1 |
Sectorielle
| Producer Manufacturing | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Entreprise privées | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Bourse
- Insiders
- Kedar Purushottam Phadke
- Expérience
